James Mullen
Net worth: 2 M $ as of 31/05/2026
Net worth: 2 M $ as of 31/05/2026
James C. Mullen is a businessperson who has been at the helm of 11 different companies and currently occupies the position of Non-Executive Chairman at Percivia LLC, Chairman, President & Chief Executive Officer of Editas Medicine, Inc. and Chief Executive Officer for DPx Holdings BV. He is also on the board of Thermo Fisher Scientific, Inc. and The Rivers School Corp. and Member of Biomedical Sciences Careers Program, Inc. In the past James C. Mullen occupied the position of Executive Chairman at Vicarius Pharma AG, President, Chief Executive Officer & Director at Biogen, Inc. Director at Biogen Idec, Inc. (North Carolina) and President at Biogen Idec New Ventures, Inc. (both are subsidiaries of Biogen, Inc.), Chairman at Torque Therapeutics, Inc., Chief Executive Officer & Non-Independent Director at Patheon, Inc., Chief Executive Officer & Executive Director at Patheon NV, Principal at GlaxoSmithKline LLC and Chairman for Biotechnology Innovation Organization. He received an MBA from Villanova University and an undergraduate degree from Rensselaer Polytechnic Institute.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/02/2026 | 3,393 ( 0% ) | 2 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
Biomedical Sciences Careers Program, Inc. | Corporate Officer/Principal | - |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Chairman | - |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Director/Board Member | 20/05/2026 |
| EDITAS MEDICINE, INC. | Chief Executive Officer | 01/06/2022 |
| INSULET CORPORATION | Director/Board Member | 28/01/2019 |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Chairman | 25/01/2019 |
| PATHEON N.V. | Chief Executive Officer | 29/08/2017 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 19 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Commercial Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Retail Trade |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions